Q1 2021

Filed May 10, 2021 · 10-Q · 40 days after period end · 0001493152-21-010887

Q1 2021 · 10-Q

Revenue—

Net Income

-$940.66K

N/M vs Q1 2020

EPS Diluted

$0.00

— vs Q1 2020

Operating Income-$665,011N/M

Operating Cash Flow-$418,653N/M

Same quarter

Metric	Q1 2021	Q1 2020	Q1 2019	Q1 2018
Revenue	—	—	$0.00	$108.63K
Net Income	-$940.66K	-$3.05M	-$477.75K	-$278.93K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR